Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Chiara, Zingaretti"'
Autor:
Jacopo Nanni, Antonino Mulè, Ernesta Audisio, Maria Paola Martelli, Barbara Scappini, Elisabetta Petracci, Irene Valli, Irene Azzali, Chiara Zingaretti, Maria Benedetta Giannini, Simona Sica, Benedetta Cambò, Anna Candoni, Monia Lunghi, Francesco Albano, Attilio Olivieri, Nicola Fracchiolla, Gian Matteo Rigolin, Massimo Bernardi, Claudio Romani, Elisabetta Todisco, Federica Gigli, Monica Bocchia, Daniela Cilloni, Nicola DI Renzo, Daniele Vallisa, Anna Maria Mianulli, Alessandro Cignetti, Francesco Lanza, Valentina Robustelli, Giorgia Simonetti, Maria Teresa Bochicchio, Giovanni Marconi, The Flam Collaborative Group, Cristina Papayannidis, Giovanni Martinelli
Publikováno v:
HemaSphere, Vol 7, p e6854054 (2023)
Externí odkaz:
https://doaj.org/article/9a5a56296c7548258e3fc905755c4710
Autor:
Joaquim Reis, Luzia Travado, Alexander Scherrer, Thanos Kosmidis, Stefanos Venios, Paris Emmanouil Laras, Gabrielle Oestreicher, Markus Moehler, Margherita Parolini, Alessandro Passardi, Elena Meggiolaro, Giovanni Martinelli, Elisabetta Petracci, Chiara Zingaretti, Sotiris Diamantopoulos, Maria Plakia, Charalampos Vassiliou, Suheib Mousa, Robert Zifrid, Francesco Giulio Sullo, Chiara Gallio
Publikováno v:
JMIR Research Protocols, Vol 12, p e45475 (2023)
BackgroundAccording to Europe’s Beating Cancer Plan, the number of cancer survivors is growing every year and is now estimated at over 12 million in Europe. A main objective of the European Commission is to ensure that cancer survivors can enjoy a
Externí odkaz:
https://doaj.org/article/e563194a52194f358562e88a8981aa68
Autor:
Linda Valmorri, Bernadette Vertogen, Chiara Zingaretti, Anna Miserocchi, Roberta Volpi, Alberto Clemente, Isabella Bondi, Irene Valli, Britt Rudnas, Giovanni Martinelli, Oriana Nanni
Publikováno v:
BMC Medical Research Methodology, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background During the COVID-19 emergency, IRST IRCCS, an Italian cancer research institute and promoter of no profit clinical studies, adapted its activities and procedures as per European and national guidelines to maintain a high standard
Externí odkaz:
https://doaj.org/article/c702eb3786cd45b0893a5f90eb46e670
Autor:
Oriana Nanni, Pierluigi Viale, Bernadette Vertogen, Claudia Lilli, Chiara Zingaretti, Caterina Donati, Carla Masini, Manuela Monti, Patrizia Serra, Roberto Vespignani, Veruska Grossi, Annibale Biggeri, Emanuela Scarpi, Francesca Galardi, Lucia Bertoni, Americo Colamartini, Fabio Falcini, Mattia Altini, Ilaria Massa, Raffaella Gaggeri, Giovanni Martinelli
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-4 (2020)
Abstract Objectives Hydroxychloroquine has shown to have antiviral activity in vitro against coronaviruses, specifically SARS-CoV-2. It is believed to block virus infection by increasing endosomal pH required for virus cell fusion and glycosylation o
Externí odkaz:
https://doaj.org/article/0ef0e112022c441aba76d83c73c15281
Autor:
Manuela Monti, Bernadette Vertogen, Carla Masini, Caterina Donati, Claudia Lilli, Chiara Zingaretti, Gerardo Musuraca, Ugo De Giorgi, Claudio Cerchione, Alberto Farolfi, Pietro Cortesi, Pierluigi Viale, Giovanni Martinelli, Oriana Nanni
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
The impact of the COVID-19 pandemic worldwide has led to a desperate search for effective drugs and vaccines. There are still no approved agents for disease prophylaxis. We thus decided to use a drug repositioning strategy to perform a state-of-the-a
Externí odkaz:
https://doaj.org/article/5e5d2500b28a41b0b95df5b3db729663
Autor:
Joaquim Reis, Luzia Travado, Alexander Scherrer, Thanos Kosmidis, Stefanos Venios, Paris Emmanouil Laras, Gabrielle Oestreicher, Markus Moehler, Margherita Parolini, Alessandro Passardi, Elena Meggiolaro, Giovanni Martinelli, Elisabetta Petracci, Chiara Zingaretti, Sotiris Diamantopoulos, Maria Plakia, Charalampos Vassiliou, Suheib Mousa, Robert Zifrid, Francesco Giulio Sullo, Chiara Gallio
BACKGROUND According to Europe’s Beating Cancer Plan, the number of cancer survivors is growing every year and is now estimated at over 12 million in Europe. A main objective of the European Commission is to ensure that cancer survivors can enjoy a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1114d838cb1dcea1579fde4b38942ffd
https://doi.org/10.2196/preprints.45475
https://doi.org/10.2196/preprints.45475
Autor:
Tea Paulović, Olivier Chartier, Maria Chiara Zingaretti, Daniele Bertolozzi, Giulia Martino, Thomas Krüger, Florent Pelsy, Linus Sioland, Lise Oulès, Antonia Custance Baker, Elise Hoek, Fabrice Nesslany, Lynn Frewer, Peter Rakers, Remco Schrijver, Steffen Foss Hansen, Steven Libbrecht
Publikováno v:
EFSA Supporting Publications. 19
Autor:
Jacopo Nanni, Ernesta Audisio, Maria Benedetta Giannini, Barbara MD Scappini, Benedetta Cambò, Francesco Albano, Maria Paola Martelli, Alessandro Cignetti, Gian Matteo Rigolin, Nicola Fracchiolla, Monica Bocchia, Claudio Romani, Elisabetta Todisco, Monia Lunghi, Anna Maria Mianulli, Daniela Cilloni, Elisabetta Petracci, Irene Valli, Chiara Zingaretti, Claudio Cerchione, Delia Cangini, the FLAM collaborative Group, Cristina Papayannidis, Giovanni Martinelli
Publikováno v:
Blood. 136:32-34
Introduction FLT3 receptor gene has been reported to be mutated in about 30% of AML, with two different kinds of mutations identified: in-frame duplications within the juxtamembrane region (FLT3-ITD) and point mutations in the tyrosine kinase domain
Autor:
Stefano Tamberi, Elisa Grassi, Chiara Zingaretti, Giorgio Papiani, Sara Pini, Jody Corbelli, Maria Di Bartolomeo, Filippo Pietrantonio, Giovanni Luca Frassineti, Alessandro Passardi, Fabio Gelsomino, Marina Marzola, Maria Banzi, Andrea Vincent Bonetti, Elisabetta Petracci, Chiara Carli Moretti, Isabella Banchelli, Davide Tassinari, Giampaolo Ugolini, Oriana Nanni
Publikováno v:
Journal of Clinical Oncology. 40:LBA3513-LBA3513
LBA3513 Background: The combination of capecitabine plus long course radiotherapy (RT) is the standard preoperative therapy in cT3-4 cN+ rectal cancer. pathologic complete remission (pCR) can be considered as surrogate endpoint of efficacy of treatme
Autor:
Claudia, Lilli, Annibale, Biggeri, Chiara, Zingaretti, Bernadette, Vertogen, Valeria, Frassineti, Roberto, Vespignani, Veruska, Grossi, Caterina, Florescu, Laura, Matteucci, Chiara, Pazzi, Alberto, Bongiovanni, Francesco, Limarzi, Valentina, Fausti, Lucia, Bertoni, Caterina, Donati, Francesca, Galardi, Nicola, Gentili, Francesco, Mazza, Giovanni, Martinelli, Oriana, Nanni
Publikováno v:
Epidemiologia e prevenzione. 45(1-2)
to examine the factors that, in the context of the current pandemic, have influenced the conduct of a randomized clinical trial on hydroxychloroquine in Italy.the trend of enrolment in the PROTECT study, "A randomized study with Hydroxychloroquine ve